Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 19;57(8):2032-2034.
doi: 10.1002/anie.201712185. Epub 2018 Jan 17.

Development of Antibody-Directed Therapies: Quo Vadis?

Affiliations

Development of Antibody-Directed Therapies: Quo Vadis?

Tiago Rodrigues et al. Angew Chem Int Ed Engl. .

Abstract

Less is more: The efficacy of antibody-drug conjugates (ADCs) for cancer therapy is traditionally associated with cleavable linkers for payload release. Evidence now suggests that simpler constructs without cleavable moieties can afford more stable and effective ADCs.

Keywords: anti-tumor agents; antibody-drug conjugates; bioconjugation; drug delivery; linkers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Common linkers used in ADCs and their drug‐release mechanisms.
Figure 2
Figure 2
ADCs with non‐cleavable linker and release mechanism of the payloads. Payloads for which the strategy has been validated are depicted. Image compiled by Claudia Flandoli.

References

    1. Atkins J. H., Gershell L. J., Nat. Rev. Drug Discovery 2002, 1, 491–492. - PubMed
    1. None
    1. Beck A., Goetsch L., Dumontet C., Corvaia N., Nat. Rev. Drug Discovery 2017, 16, 315–337; - PubMed
    1. Beck A., Haeuw J. F., Wurch T., Goetsch L., Bailly C., Corvaia N., Discovery Med. 2010, 10, 329–339. - PubMed
    1. Krall N., da Cruz F. P., Boutureira O., Bernardes G. J., Nat. Chem. 2016, 8, 103–113. - PubMed

Publication types